Diagnostic and Interventional Cardiology

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

News | Cardiac Diagnostics

Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum ...

October 06, 2020

The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF Ablation Catheter for the treatment of persistent atrial fibrillation (persistent AF).

News | Atrial Fibrillation

FDA Clears Biosense Webster ThermoCool SmartTouch SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation

October 6, 2020 – The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF ...

October 06, 2020

Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images

News | Heart Failure

ACC and Novartis Collaborate to Optimize Heart Failure Care With TRANSFORM Study

October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In ...

October 05, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | VIVA

The Latest Vascular Interventional Clinical Data Presented at VIVA 2020

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

October 05, 2020

Webinar | Cardiovascular Information Systems (CVIS)

WEBINAR: Intelligently Efficient Adult Echo Structured Reporting

The dynamics of our world are changing rapidly. Cardiologists are being challenged to complete documentation in an ...

October 05, 2020

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.

Feature | Coronavirus (COVID-19)

Cardiac Arrest With Poor Survival Common in Sickest COVID-19 Patients

October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily ...

October 02, 2020

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.

News | Heart Valve Technology

Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

October 02, 2020

Videos | Left Atrial Appendage (LAA) Occluders

VIDEO: Overview of Left Atrial Appendage (LAA) Closure Technology and New Innovations

Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal ...

October 02, 2020

The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with 3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.

News | Hybrid OR

Intelligent Hybrid Operating Room Help Redefine Cardiac Care at London Health Sciences Centre

October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario ...

October 02, 2020

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

The FDA granted 510(k) clearance for the SentiAR CommandEP system, the first holographic guidance system to be used during an invasive electrophysiology (EP) lab cardiac procedures. The system allows electrophysiologists to visualize 3-D electro-anatomic models in real-time, via a wearable headset and offer a truly handsfree control interface providing superior visualization, allowing them to navigate accurately within the heart during a cardiac ablation procedure.

News | Virtual and Augmented Reality

FDA Clears First Holographic Cardiac Ablation Guidance System

October 1, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the SentiAR CommandEP system ...

October 01, 2020

Videos | EP Lab

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health

Peter Weiss M.D., MSc, director of ventricular arrhythmia management and robotics, and assistant clinical professor of ...

October 01, 2020

The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.

News | Stents

Medtronic Resolute Onyx Drug Eluting Stent First to Receive One-Month DAPT Indication

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

October 01, 2020

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.

News | Optical Coherence Tomography (OCT)

World’s Smallest Intravascular OCT Imaging Device Created Using 3-D Printing

October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D micro ...

October 01, 2020

The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.

Feature | Dave Fornell, Editor

October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

October 01, 2020

Videos | EP Lab

VIDEO: Advantages of Robotic Ablation in the EP Lab

Peter Weiss M.D., MSc, director of ventricular arrhythmia management and robotics, and assistant clinical professor of ...

September 30, 2020